Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
37.68 Up 0.67(1.81%) 4:00PM EDT
Prev Close:37.01
Open:36.68
Bid:36.60 x 1000
Ask:38.89 x 200
1y Target Est:82.63
Beta:2.08
Next Earnings Date: 7-Aug-14CLVS Earnings announcement
Day's Range:36.50 - 37.77
52wk Range:35.86 - 93.33
Volume:274,618
Avg Vol (3m):937,417
Market Cap:1.28B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLVSUp 1.81%1.28B
IMMUDown 2.91%278.91M
LRUSF 0.00%61.44M
THLDDown 1.20%244.51M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):92.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.84
Quarterly EPS Est (Jun-14) :-0.95
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback